MedTrace Logo

Pancreatic Juice Diagnosis From Duodenum

NCT01699698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2015-09-21

Study results available
· View outcomes & findings →

Summary

Purpose of this study is to understand the clinical feasibility of duodenal juice diagnosis to screen UICC stage II pancreatic ductal adenocarcinoma patients.

Conditions

  • Pancreatic Adenocarcinoma

Interventions

OTHER

Tumor markers

Duodenal juice are collected using endoscope and cannula. Tumor markers of collected samples are analyzed. The marker concentration is applied to statistical analysis.

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Kyushu University

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Olympus Corporation

    lead INDUSTRY

Principal Investigators

  • Massimo Raimondo, M.D. · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-07-31

Countries

  • United States
  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01699698 on ClinicalTrials.gov